BOSTON--(BUSINESS WIRE)--July 27, 2006--PerkinElmer, Inc. (NYSE: PKI - News), a global leader in Health Sciences and Photonics markets, today announced that it has signed a multi-year, multi-million dollar agreement to supply the state of Texas with instruments, software and reagents to enhance the Texas newborn screening program. The technology will be used to test for metabolic disorders in the estimated 375,000 infants born in Texas each year.
